we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of viscosupplementation injections. This recommendation is conditional because there may be exceptions to this recommendation, and the evidence supporting the recommendation is indirect and very low quality. The data on viscosupplementation for patients who are otherwise candidates for TJA were very limited. Viscosupplementation may place an unnecessary burden on the patient, with limited